Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain–Barré syndrome

References

• Nachamkin I. Chronic effects of Campylobacter infection. Microbes Infect 2002;4:399–403.
   PubMed Web of Science ®Google Scholar
• Winer JB. Guillain–Barre syndrome. Mol Pathol. 2001;54:381–5.
   PubMedGoogle Scholar
• Allos BM. Association between Campylobacter infection and Guillain–Barre syndrome. J Infect Dis 1997;176(Suppl. 2):S125–8.
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 cells. Annu Rev Immunol 2009;27:485–517.
   PubMed Web of Science ®Google Scholar
• Paradowska A, Masliniski W, Grzybowska-Kowalczyk A, et al. The function of interleukin 17 in the pathogenesis of rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) 2007;55:329–34.
   PubMed Web of Science ®Google Scholar
• Chi LJ, Xu WH, Zhang ZW, et al. Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2010;15:345–56.
   PubMed Web of Science ®Google Scholar
• Kebir H, Kreymborg K, Ifergan I, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007;13:1173–5.
   PubMed Web of Science ®Google Scholar
• Kawaguchi M, Takahashi D, Hizawa N, et al. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol 2006;117:795–801.
   PubMed Web of Science ®Google Scholar
• Arisawa T, Tahara T, Shibata T, et al. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol 2008;28:44–9.
   PubMed Web of Science ®Google Scholar
• Jang WC, Nam YH, Ahn YC, et al. Interleukin-17F gene polymorphisms in Korean patients with Behcet's disease. Rheumatol Int 2008;29:173–8.
   PubMed Web of Science ®Google Scholar
• Seiderer J, Elben I, Diegelmann J, et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008;14:437–45.
   PubMed Web of Science ®Google Scholar
• Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol 1999;162:494–502.
   PubMed Web of Science ®Google Scholar
• Diamond MS, Staunton DE, Marlin SD, et al. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991;65:961–71.
   PubMed Web of Science ®Google Scholar
• Salmaso C, Olive D, Pesce G, et al. Costimulatory molecules and autoimmune thyroid diseases. Autoimmunity 2002;35:159–67.
   PubMed Web of Science ®Google Scholar
• Brand S, Beigel F, Olszak T, et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006;290:G827–38.
   PubMed Web of Science ®Google Scholar
• Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin-17 in inflammatory bowel disease. Gut 2003;52:65–70.
   PubMed Web of Science ®Google Scholar
• Metawi SA, Abbas D, Kamal MM, et al. Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol 2011;30:1201–7.
   PubMed Web of Science ®Google Scholar
• Matusevicius D, Kivisakk P, He B, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 1999;5:101–4.
   PubMed Web of Science ®Google Scholar
• Li C, Zhao P, Sun X, et al. Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain–Barré syndrome. Mediators Inflamm 2013;2013:639712.
   PubMed Web of Science ®Google Scholar
• Li S, Jin T, Zhang H, et al. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain–Barré syndrome and downregulated by IVIg treatments. Mediators Inflamm 2014;2014:740947.
   PubMed Web of Science ®Google Scholar
• Han R, Cheng Y, Zhou S, et al. Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain–Barré syndrome. J Clin Immunol 2014;34:94–103.
   PubMed Web of Science ®Google Scholar
• Wang X, Zheng X, Ma C, et al. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis. Scand J Immunol 2014;80:189–90.
   Web of Science ®Google Scholar
• Navarro-Hernandez RE, Oregon-Romero E, Vazquez-Del Mercado M, et al. Expression of ICAM1 and VCAM1 serum levels in rheumatoid arthritis clinical activity. Association with genetic polymorphisms. Dis Markers 2009;26:119–26.
   PubMed Web of Science ®Google Scholar
• McMurray RW. Adhesion molecules in autoimmune disease. Semin Arthritis Rheum 1996;25:215–33.
   PubMed Web of Science ®Google Scholar
• Duran I, Martinez-Caceres EM, Rio J, et al. Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules. Brain 1999;122(Pt 12):2297–307.
   PubMed Web of Science ®Google Scholar
• Sipkins DA, Gijbels K, Tropper FD, et al. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. J Neuroimmunol 2000;104:1–9.
   PubMed Web of Science ®Google Scholar
• Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barre syndrome. Ann Neurol 1990;27 Suppl:S21–4.
   PubMed Web of Science ®Google Scholar
• Hadden R, Cornblath D, Hughes R. Electrophysiological classification of Guillain–Barrê syndrome: clinical associations and outcome. Plasma exchange/Sandoglobulin Guillain–Barrê Syndrome Trial Group. Ann Neurol 1998;44:780–8.
   PubMed Web of Science ®Google Scholar
• Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
   PubMed Web of Science ®Google Scholar
• Paradowska-Gorycka A, Wojtecka-Lukasik E, Trefler J, et al. Association between IL-17F gene polymorphisms and susceptibility to and severity of rheumatoid arthritis (RA). Scand J Immunol 2010;72:134–41.
   PubMed Web of Science ®Google Scholar
• Li S, Yu M, Li H, et al. IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain–Barre syndrome. Mediators Inflamm 2012;2012:260473.
   PubMed Web of Science ®Google Scholar
• Redford EJ, Hall SM, Smith KJ. Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain 1995;118(Pt 4):869–78.
   PubMed Web of Science ®Google Scholar
• Zhu J, Mix E, Link H. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain–Barre syndrome. J Neuroimmunol 1998;84:40–52.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang ZY, Schluesener HJ. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects. J Immunol 2009;183:3081–91.
   PubMed Web of Science ®Google Scholar
• Shen F, Gaffen SL. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 2008;41:92–104.
   PubMed Web of Science ®Google Scholar
• Zepp J, Wu L, Li X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol 2011;32:232–9.
   PubMed Web of Science ®Google Scholar
• Carrithers MD, Visintin I, Kang SJ, et al. Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain 2000;123(Pt 6):1092–101.
   PubMed Web of Science ®Google Scholar
• Mycko MP, Kwinkowski M, Tronczynska E, et al. Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann Neurol 1998;44:70–5.
   PubMed Web of Science ®Google Scholar
• Constantin G, Piccio L, Bussini S, et al. Induction of adhesion molecules on human Schwann cells by proinflammatory cytokines, an immunofluorescence study. J Neurol Sci 1999;170:124–30.
   PubMed Web of Science ®Google Scholar
• Nejentsev S, Laaksonen M, Tienari PJ, et al. Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis. Hum Immunol 2003;64:345–9.
   PubMed Web of Science ®Google Scholar
• Sainaghi P, Collimedaglia L, Alciato F, et al. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain–Barre syndrome from chronic inflammatory demyelinating polyneuropathy. Cytokine 2010;51:138–43.
   PubMed Web of Science ®Google Scholar
• Putzu G, Figarella-Branger D, Bouvier-Labit C, et al. Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain–Barré syndrome. J Neurol Sci 2000;174:16–21.
   PubMed Web of Science ®Google Scholar
• Stoll G, Jung S, Jander S, et al. Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol 1993;45:175–82.
   PubMed Web of Science ®Google Scholar
• Tran G, Hodgkinson S, Carter N, et al. Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis. J Neuroimmunol 2010;229:98–106.
   PubMed Web of Science ®Google Scholar
• Archelos J, Maurer M, Jung S, et al. Suppression of experimental allergic neuritis by an antibody to the intracellular adhesion molecule ICAM-1. Brain 1993;116:1043–58.
   PubMed Web of Science ®Google Scholar
• Langert K, Von Zee C, Stubbs E, Jr. Tumour necrosis factor α enhances CCL2 and ICAM-1 expression in peripheral nerve microvascular endoneurial endothelial cells. ASN Neuro. 2013;5:e00104.
   PubMed Web of Science ®Google Scholar
• Hadden R, Karch H, Hartung H, et al. Group PESG-BST. Preceding infections, immune factors, and outcome in Guillain–Barré syndrome. Neurology 2001;56:758–65.
   PubMed Web of Science ®Google Scholar
• Musso AM, Zanusso GL, Bonazzi ML, et al. Increased serum levels of ICAM-1, ELAM-1 and TNF-alpha in inflammatory disorders of the peripheral nervous system. Ital J Neurol Sci 1994;15:267–71.
   PubMedGoogle Scholar
• Lisak RP, Bealmear B. Upregulation of intercellular adhesion molecule-1 (ICAM-1) on rat Schwann cells in vitro: comparison of interferon-gamma, tumor necrosis factor-alpha and interleukin-1. J Peripher Nerv Syst 1997;2:233–43.
   PubMedGoogle Scholar
• Prasad KN, Nyati KK, Verma A, et al. Tumor necrosis factor-alpha polymorphisms and expression in Guillain–Barre syndrome. Hum Immunol 2010;71:905–10.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Benveniste EN. Adhesion molecule expression and regulation on cells of the central nervous system. J Neuroimmunol 1999;98:77–88.
   PubMed Web of Science ®Google Scholar
• Killestein J, Schrijver HM, Crusius JB, et al. Intracellular adhesion molecule-1 polymorphisms and genetic susceptibility to multiple sclerosis: additional data and meta-analysis. Ann Neurol 2000;47:277–9.
   PubMed Web of Science ®Google Scholar
• Taylor JG, Tang DC, Savage SA, et al. Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 2002;100:4303–9.
   PubMed Web of Science ®Google Scholar
• Wenzel K, Ernst M, Rohde K, et al. DNA polymorphisms in adhesion molecule genes–a new risk factor for early atherosclerosis. Hum Genet 1996;97:15–20.
   PubMed Web of Science ®Google Scholar
• Macchioni P, Boiardi L, Casali B, et al. Intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in Italian patients with rheumatoid arthritis. Clin Exp Rheumatol 2000;18:553–8.
   PubMed Web of Science ®Google Scholar
• Lee EB, Kim JY, Kim EH, et al. Intercellular adhesion molecule-1 polymorphisms in Korean patients with rheumatoid arthritis. Tissue Antigens 2004;64:473–7.
   PubMedGoogle Scholar
• Ponthieux A, Lambert D, Herbeth B, et al. Association between Gly241Arg ICAM-1 gene polymorphism and serum sICAM-1 concentration in the Stanislas cohort. Eur J Hum Genet 2003;11:679–86.
   PubMed Web of Science ®Google Scholar
• Cai XY, Gommoll CP, Jr., Justice L, et al. Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17. Immunol Lett 1998;62:51–8.
   PubMed Web of Science ®Google Scholar
• Schwarzenberger P, Huang W, Ye P, et al. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol 2000;164:4783–9.
   PubMed Web of Science ®Google Scholar
• Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996;183:2593–603.
   PubMed Web of Science ®Google Scholar
• Jovanovic DV, Di Battista JA, Martel-Pelletier J, et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998;160:3513–21.
   PubMed Web of Science ®Google Scholar
• Zameer A, Hoffman SA. Immunoglobulin binding to brain in autoimmune mice. J Neuroimmunol 2001;120:10–8.
   PubMed Web of Science ®Google Scholar